Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced NSCLC × Oxaliplatin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 437 Stomach Neoplasms 290 Rectal Neoplasms 264 Colonic Neoplasms 190 Pancreatic Neoplasms 172 Neoplasm Metastasis 110 Esophageal Neoplasms 86 Neoplasms 68 Carcinoma, Hepatocellular 59 Adenocarcinoma Of Esophagus 46 Adenocarcinoma 46 Lymphoma, Large B-Cell, Diffuse 43 Cholangiocarcinoma 43 Carcinoma, Non-Small-Cell Lung 41 Biliary Tract Neoplasms 35 Gallbladder Neoplasms 30 Gastrointestinal Neoplasms 29 Recurrence 25 Liver Neoplasms 24 Ovarian Neoplasms 23 Esophageal Squamous Cell Carcinoma 22 Breast Neoplasms 22 Peritoneal Neoplasms 17 Bile Duct Neoplasms 17 Unspecified Adult Solid Tumor, Protocol Specific 16 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Head and Neck Neoplasms 13 Lung Neoplasms 12 Locally Advanced Rectal Cancer 12 Appendiceal Neoplasms 11

Interventions

Radiotherapy 4 Immune Checkpoint Inhibitors 4 famitinib 1 camrelizumab 1 aflutinib 1 Oxaliplatin 1 Nivolumab 1 Ipilimumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡